Luminescent lanthanide chelate contrast agents and detection of lesions in the hamster oral cancer model

被引:30
作者
Bornhop, DJ
Griffin, JMM
Goebel, TS
Sudduth, MR
Bell, B
Motamedi, M
机构
[1] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA
[2] Univ Texas, Med Branch, Galveston, TX 77550 USA
关键词
contrast agents; lanthanide chelates; terbium; oral cancer; fluorescence imaging; VIVO FLUORESCENCE SPECTROSCOPY; LASER-INDUCED FLUORESCENCE; HUMAN SKIN TUMORS; IN-VIVO; PORPHYRIN FLUORESCENCE; TOLUIDINE BLUE; NECK-CANCER; AUTOFLUORESCENCE; DYSPLASIA; CARCINOMA;
D O I
10.1366/000370203769699063
中图分类号
TH7 [仪器、仪表];
学科分类号
0804 ; 080401 ; 081102 ;
摘要
Lanthanide chelates are a somewhat unique class of molecules that have proven to be useful in the biomedical field due to their extremely large Stokes' shift and long fluorescent lifetimes. The ability of these molecules to produce fluorescence in the low- or zero-background regime makes this class of molecules excellent candidates for use as contrast agents for a wide variety of applications in biological settings. Here we present the preparation, spectroscopic characterization, and application of a new terbium chelate contrast agent, based on the 1,4,7,10-tetraazacyclododecane macrocycle (cyclen), for detection of early-stage malignant lesions in the Syrian hamster cheek pouch. Tb-P(CTMB) delivers bright blue-green luminescence when excited with low photon fluxes of UV light. As a pilot study, the DMBA-treated Golden Hamster Cheek pouch epithelial cancer model was employed and Tb-P(CTMB) was used as a topical agent for the visual detection of diseased tissue. In this preliminary study the agent tended to associate with early-stage malignant lesions, suggesting that Tb-P(CTMB) could be used as a contrast agent to aid in identifying early-stage oral cancer lesions.
引用
收藏
页码:1216 / 1222
页数:7
相关论文
共 43 条
  • [1] Abe S, 2000, ENDOSCOPY, V32, P281
  • [2] Becker Andreas, 2000, V921, P275
  • [3] Betz CS, 1999, LASER SURG MED, V25, P323, DOI 10.1002/(SICI)1096-9101(1999)25:4<323::AID-LSM7>3.0.CO
  • [4] 2-P
  • [5] Fluorescent tissue site-selective lanthanide chelate, Tb-PCTMB for enhanced imaging of cancer
    Bornhop, DJ
    Hubbard, DS
    Houlne, MP
    Adair, C
    Kiefer, GE
    Pence, BC
    Morgan, DL
    [J]. ANALYTICAL CHEMISTRY, 1999, 71 (14) : 2607 - 2615
  • [6] Prognosis of patients with recurrent laryngeal carcinoma
    Brenner, B
    Marshak, G
    Sulkes, A
    Rakowsky, E
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2001, 23 (07): : 531 - 535
  • [7] Detection of dysplasia at colonoscopy using laser-induced fluorescence: A blinded study
    Cothren, RM
    Sivak, MV
    VanDam, J
    Petras, RE
    Fitzmaurice, M
    Crawford, JM
    Wu, J
    Brennan, JF
    Rava, RP
    Manoharan, R
    Feld, MS
    [J]. GASTROINTESTINAL ENDOSCOPY, 1996, 44 (02) : 168 - 176
  • [8] TOLUIDINE BLUE AND LUGOL IODINE APPLICATION IN THE ASSESSMENT OF ORAL MALIGNANT DISEASE AND LESIONS AT RISK OF MALIGNANCY
    EPSTEIN, JB
    SCULLY, C
    SPINELLI, J
    [J]. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1992, 21 (04) : 160 - 163
  • [9] Gillenwater A, 1998, HEAD NECK-J SCI SPEC, V20, P556, DOI 10.1002/(SICI)1097-0347(199809)20:6<556::AID-HED11>3.0.CO
  • [10] 2-O